Reported Standalone quarterly numbers for Mangalam Drugs & Organics are:
Net Sales at Rs 81.56 crore in September 2023 down 24.71% from Rs. 108.33 crore in September 2022.
Story continues below Advertisement
Quarterly Net Loss at Rs. 3.56 crore in September 2023 down 259.9% from Rs. 2.23 crore in September 2022.
EBITDA stands at Rs. 2.22 crore in September 2023 down 73.7% from Rs. 8.44 crore in September 2022.
Mangalam Drugs shares closed at 99.60 on November 09, 2023 (NSE) and has given -11.62% returns over the last 6 months and -28.96% over the last 12 months.
Story continues below Advertisement
| Mangalam Drugs & Organics | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'23 | Jun'23 | Sep'22 | | Net Sales/Income from operations | 81.56 | 87.00 | 108.33 | | Other Operating Income | -- | 0.46 | -- | | Total Income From Operations | 81.56 | 87.47 | 108.33 | | EXPENDITURE | | Consumption of Raw Materials | 66.90 | 59.66 | 73.24 | | Purchase of Traded Goods | 0.64 | 0.00 | 12.51 | | Increase/Decrease in Stocks | -16.82 | 6.21 | -12.10 | | Power & Fuel | -- | -- | -- | | Employees Cost | 10.11 | 8.89 | 9.54 | | Depreciation | 3.73 | 3.42 | 2.76 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 18.54 | 16.19 | 16.70 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -1.54 | -6.89 | 5.68 | | Other Income | 0.03 | 0.02 | 0.00 | | P/L Before Int., Excpt. Items & Tax | -1.51 | -6.87 | 5.68 | | Interest | 3.24 | 3.41 | 2.56 | | P/L Before Exceptional Items & Tax | -4.75 | -10.29 | 3.12 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -4.75 | -10.29 | 3.12 | | Tax | -1.19 | -0.75 | 0.90 | | P/L After Tax from Ordinary Activities | -3.56 | -9.54 | 2.23 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -3.56 | -9.54 | 2.23 | | Equity Share Capital | 15.83 | 15.83 | 15.83 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -2.25 | -6.02 | 1.41 | | Diluted EPS | -2.25 | -6.02 | 1.41 | | EPS After Extra Ordinary | | Basic EPS | -2.25 | -6.02 | 1.41 | | Diluted EPS | -2.25 | -6.02 | 1.41 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
